Media

Press releases

Regulatory

November 20, 2023

Amniotics receives positive opinion on orphan designation for PulmoStem® from the European Medicines Agency for the Treatment of Primary Graft Dysfunction following Lung Transplantation

Regulatory

November 20, 2023

Amniotics erhåller positivt utlåtande av den europeiska läkemedelsmyndigheten gällande särläkemedelsstatus för PulmoStem® vid behandling av Primary Graft Dysfunction i samband med lungtransplantation

Regulatory

September 6, 2023

Amniotics procures top guarantee commitments and enters into additional subscription undertakings for a fully secured rights issue

Regulatory

September 6, 2023

Amniotics upphandlar toppgarantiåtaganden samt ingår ytterligare teckningsförbindelser för en fullt säkerställd företrädesemission

Regulatory

August 31, 2023

Amniotics genomför en företrädesemission av units om cirka 25 MSEK säkerställd till cirka 80 procent

Regulatory

August 31, 2023

Amniotics resolves on a rights issue of units of approximately SEK 25 million secured to approximately 80 percent

Regulatory

May 25, 2023

Amniotics receives positive topline results from clinical phase Ib study with PulmoStem

Regulatory

May 25, 2023

Amniotics erhåller positiva studieresultat från klinisk fas-I studie med PulmoStem

Regulatory

January 17, 2023

Kallelse till extra bolagsstämma i Amniotics AB (publ)

Regulatory

January 17, 2023

Amniotics cancels the planned extraordinary general meeting and presents a new timetable for the planned rights issue

Upcoming events